Showing results (31-40 of 171) with videos related to
Sort By:
Pageof 18
European Journal of Radiology|July 19, 2018
Inter-reader agreement of CT features of acute mesenteric ischemiaPauline Copin, Maxime Ronot, Alexandre Nuzzo, et al.Journal of Pediatric Gastroenterology and Nutrition|February 2, 2023
PERFUSE: Non-Interventional Cohort Study of Patients Receiving Infliximab Biosimilar SB2: Results in Pediatric PatientsChristine Martinez-Vinson, Anaïs Lemoine, Yoram Bouhnik, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 12, 2023
The PERFUSE study: The experience of patients receiving Adalimumab biosimilar SB5Yoram Bouhnik, Franck Carbonnel, Mathurin Fumery, et al.Gastroenterologie Clinique Et Biologique|June 2, 2007
Appendectomy, smoking habits and the risk of developing ulcerative colitis: a case control study in private practice settingPhilippe de Saussure, Pierre Clerson, Pierre-Louis Prost, et al.Inflammatory Bowel Diseases|October 9, 2004
Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease?Arnaud Alves, Yves Panis, Francisca Joly, et al.Annals of Surgery|October 26, 2012
Segmental reversal of the small bowel can end permanent parenteral nutrition dependency: an experience of 38 adults with short bowel syndromeLaura Beyer-Berjot, Francisca Joly, Léon Maggiori, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 14, 2020
Monitoring of inflammatory bowel disease in 2019: A French consensus for clinical practiceGuillaume Bonnaud, Yoram Bouhnik, Hervé Hagege, et al.Journal of Vascular Surgery|August 6, 2015
Revascularization of acute mesenteric ischemia after creation of a dedicated multidisciplinary centerArnaud Roussel, Yves Castier, Alexandre Nuzzo, et al.Rheumatology Advances in Practice|May 1, 2023
Real-world evidence of the use of the infliximab biosimilar SB2: data from the PERFUSE studyBruno Fautrel, Yoram Bouhnik, Philippe Dieude, et al.Clinical Drug Investigation|August 24, 2023
Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature ReviewHéctor Corominas, David Young, J R Fraser Cummings, et al.Pageof 18